SG11202001595SA - Angio-3 for treatment of retinal angiogenic diseases - Google Patents

Angio-3 for treatment of retinal angiogenic diseases

Info

Publication number
SG11202001595SA
SG11202001595SA SG11202001595SA SG11202001595SA SG11202001595SA SG 11202001595S A SG11202001595S A SG 11202001595SA SG 11202001595S A SG11202001595S A SG 11202001595SA SG 11202001595S A SG11202001595S A SG 11202001595SA SG 11202001595S A SG11202001595S A SG 11202001595SA
Authority
SG
Singapore
Prior art keywords
angio
treatment
angiogenic diseases
retinal angiogenic
retinal
Prior art date
Application number
SG11202001595SA
Inventor
Veluchamy Amutha Barathi
Rajamani Lakshminarayanan
R Manjunatha Kini
Michael Belkin
Ge Ruowen
Tien Yin Wong
Gemmy Chui Ming Cheung
Original Assignee
Singapore Health Serv Pte Ltd
Nat Univ Singapore
Michael Belkin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Serv Pte Ltd, Nat Univ Singapore, Michael Belkin filed Critical Singapore Health Serv Pte Ltd
Publication of SG11202001595SA publication Critical patent/SG11202001595SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11202001595SA 2017-08-31 2018-08-31 Angio-3 for treatment of retinal angiogenic diseases SG11202001595SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762553051P 2017-08-31 2017-08-31
PCT/IB2018/056685 WO2019043649A2 (en) 2017-08-31 2018-08-31 Angio-3 for treatment of retinal angiogenic diseases

Publications (1)

Publication Number Publication Date
SG11202001595SA true SG11202001595SA (en) 2020-03-30

Family

ID=65525123

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001595SA SG11202001595SA (en) 2017-08-31 2018-08-31 Angio-3 for treatment of retinal angiogenic diseases

Country Status (7)

Country Link
US (2) US11266710B2 (en)
EP (1) EP3675889A4 (en)
JP (1) JP2020532586A (en)
CN (1) CN111344002A (en)
AU (1) AU2018326835A1 (en)
SG (1) SG11202001595SA (en)
WO (1) WO2019043649A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
SG11201805420SA (en) 2015-12-30 2018-07-30 Kodiak Sciences Inc Antibodies and conjugates thereof
SG11202008242XA (en) 2018-03-02 2020-09-29 Kodiak Sciences Inc Il-6 antibodies and fusion constructs and conjugates thereof
CN114786731A (en) 2019-10-10 2022-07-22 科达制药股份有限公司 Methods of treating ocular disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902790A (en) * 1995-10-03 1999-05-11 Cytran, Inc. Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5837682A (en) * 1996-03-08 1998-11-17 The Children's Medical Center Corporation Angiostatin fragments and method of use
EP0824546B1 (en) * 1995-04-26 2007-07-25 The Children's Medical Center Corporation Angiostatin fragments and methods of use
US7317003B2 (en) * 1998-09-04 2008-01-08 National University Of Singapore Small peptides having anti-angiogenic and endothelial cell inhibition activity
SG87828A1 (en) * 1999-09-03 2002-04-16 Univ Singapore Small peptides having potent anti-angiogenic activity
JP2005538932A (en) * 2002-02-07 2005-12-22 アベンティス、ベーリング、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング Albumin fusion Kunitz domain peptide
NZ535100A (en) 2002-03-20 2008-04-30 Univ Florida RAAV vector compositions and methods for the treatment of choroidal neovascularization
CN101942012A (en) 2009-07-08 2011-01-12 上海市第一人民医院 Polypeptide for preventing and treating angiogenesis and application thereof
DK2575881T3 (en) * 2010-05-28 2017-01-09 Inst Nat Sante Rech Med Specific anti-CD160-antibodies for the treatment of eye diseases on the basis of neoangiogenesis
TW201427989A (en) * 2012-12-18 2014-07-16 Novartis Ag Compositions and methods for long acting proteins
CN105683211B (en) * 2013-10-28 2020-10-20 拜斯科阿迪有限公司 Novel polypeptides

Also Published As

Publication number Publication date
WO2019043649A2 (en) 2019-03-07
EP3675889A4 (en) 2021-05-12
US11266710B2 (en) 2022-03-08
WO2019043649A3 (en) 2019-05-02
CN111344002A (en) 2020-06-26
US20200246417A1 (en) 2020-08-06
EP3675889A2 (en) 2020-07-08
JP2020532586A (en) 2020-11-12
US20220175876A1 (en) 2022-06-09
AU2018326835A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
HRP20190117T1 (en) Mrna therapy for the treatment of ocular diseases
IL276383A (en) Treatment of ophthalmologic diseases
IL268357A (en) Photoreceptor cells for the treatment of retinal diseases
ZA201903003B (en) Treatment of neurological diseases
SG11202001595SA (en) Angio-3 for treatment of retinal angiogenic diseases
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
IL270362B (en) Treatment of glaucoma
IL269698B (en) Methods of preventing or treating ophthalmic diseases
GB201805100D0 (en) Treatment of sarcopenic diseases
IL259381B (en) Mirabegron for the treatment of retinal diseases
PL3515409T3 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases
GB201604359D0 (en) Treatment of tissue disorders
PL3302463T3 (en) Use of 3-deoxyanthocyanidins for treating ocular diseases
IL263837A (en) Treatment of ocular disease
IL274132A (en) Treatment of skin disorders
GB201705435D0 (en) Treatment of ocular disease
EP3710043C0 (en) Fgf10 for the treatment of heart diseases
GB201811911D0 (en) Treatment of disease
GB201811912D0 (en) Treatment of disease
GB201810974D0 (en) Treatment of disease
GB201805556D0 (en) Treatment of ophthalmological conditions
GB201610938D0 (en) Treatment of ocular disease
GB201706662D0 (en) Treatment of neurological diseases
GB201621398D0 (en) Treatment of emt-associated disease
GB201614076D0 (en) Diagnosis and treatment of ocular disorders